Neonatal Abstinence Syndrome. Neonatal withdrawal symptoms from maternal use of drugs of addiction
Conditions
Interventions
Intervention 1: Intervention group: Randomized clinical trial study in 60 neonate. 2 group of neonatal abstinence syndrome that randomized divided to 2 group of Buprenorphine (intervention group 30 ne
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 7 Days
Inclusion criteria
Inclusion criteria: Postnatal Age<7 Days Gestational Age= 35 Weeks Prenatal Opium Exposure Symptomatic Patient And 3 Fingan Score =8 In 3 Hours Or 2 Fingan Score=12 No Siezure History No Major Congenital Anomaly No Unstablity In Blood Pressure And Hemodynamic No Major Medical Unstability In Association Of Withdrawal Syndrome
Exclusion criteria
Exclusion criteria: Analgesic Consumption and withdrawal syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Admit Duration. Timepoint: Duration of Admit. Method of measurement: Observation of physician.;Drugs Complications. Timepoint: Admit Duration. Method of measurement: Observation of physician.;Apnea. Timepoint: Admit Duration. Method of measurement: Observation of physician.;Feeding. Timepoint: Admit Duration. Method of measurement: Observation of physician.;Blood Pressure. Timepoint: Admit Duration. Method of measurement: Mercurial Pressure-Gauge Device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGholamreza Faal
Birjand University of Medical Sciences
Outcome results
None listed